3B BLACKBIO DX LTD. Share Price

3B Blackbio DX Limited is an India-based company, which is engaged in the field of polymerase chain reaction (PCR)-based Molecular Diagnostic Kits. Its segments include Agrochemicals and Diagnostic kits. The diagnostics division of the Company is engaged in Design, Development Manufacturing and Commercialization of qPCR tests, Rapid tests, Next Gen Sequencing (NGS)-based Molecular Diagnostic Kits and Extraction Kits for reliable testing on patient samples. Its products include Oncology and Hematology, Antimicrobial Resistance, Infectious Diseases, Human Genetics, Extraction, and Rapid Antigen Kits. The PCR-based Molecular Diagnostic Kits are commercialized with TRUPCR brand to renowned diagnostics labs across the country. The Company also has a Lateral Flow Assays Vertical and a NGS Assay development division. The lateral flow assays are commercialized under the brand name TRURAPID and the NGS assays are commercialized under the brand name TRUNGS.As of 25 May 2026, 3B BLACKBIO DX LTD. share price is ₹1,235.00. The stock opened at ₹1,218.90, compared to its previous close of ₹1,206.10. During today's trading session, 3B BLACKBIO DX LTD. share price moved in the range of ₹1,203.10 to ₹1,258.90, with an average price of ₹1,231.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,203.10 and a high of ₹1,258.90. On the performance front, 3B BLACKBIO DX LTD. share price has declined by 4.82% over the last six months and is down 4.82% on a year-on-year basis.

The market capitalization of 3B BLACKBIO DX LTD. is ₹1,029 Crs, with a P/E ratio of 17.7 and a dividend yield of 0.33%.